Could you share your thoughts on the complexity of the AMR issue?
AMR is indeed a multifaceted challenge. Primarily, it stems from the widespread and inappropriate use of antibiotics. For instance, during the flu season, there’s a tendency to prescribe antibiotics like azithromycin for viral infections, which is ineffective and leads to cross-resistance. This is just one facet of the rampant misuse of antibiotics.
Are there other factors contributing to AMR?
Absolutely. Environmental factors play a significant role too. The inadequate treatment of waste by antibiotic-producing companies results in environmental contamination, which in turn contributes to the emergence of superbugs. This is a serious concern that needs addressing.
What about the research and development aspect in antibiotics?
The field of antibiotics, unfortunately, doesn’t receive adequate investment from larger companies. This is partly because infectious diseases are often perceived as more prevalent in developing countries. Consequently, there’s a lack of motivation to invest in antibiotic research, which is seen as less profitable.
As a leader in pharmaceuticals, what is Dr. Reddy’s Laboratories’ approach to AMR research?
While we recognize the critical importance of AMR, our research efforts at Dr. Reddy’s are primarily focused on oncology. We do produce some generic antibiotics, but our innovative research does not currently extend to antimicrobial research.
Could you elaborate on the role of AI in addressing AMR?
AI is proving to be a valuable tool in drug discovery. It aids in understanding the dynamics of molecule manipulation and can potentially play a role in developing new compounds, particularly for known protein structures. AI can also contribute to understanding resistance mechanisms and ways to counteract them. However, it’s important to note that the major cost in drug development is not just the discovery phase but also in the subsequent stages like clinical trials.
Considering the commercial aspects, how should antibiotic stewardship be balanced with profitable projects?
Antibiotic stewardship is a responsibility that extends beyond the private sector. It requires government funding and intervention. There’s also a critical need for better regulation of antibiotic use to prevent overuse and misuse. Governments play a pivotal role in regulating the use of antibiotics and ensuring that certain drugs are reserved as a last resort.
